Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Nutt

Showing results (11-20 of 388) with videos related to

Pageof 39
Sort By:
Human Psychopharmacology|October 31, 2002
Tolerability and safety aspects of mirtazapineDavid J Nutt
Journal of Psychopharmacology (Oxford, England)|May 13, 2005
Making sense of GABA(A) receptor subtypes: is a new nomenclature needed?David J Nutt
Journal of Psychopharmacology (Oxford, England)|September 30, 2003
The unhappy saga of 'happy pills'David J Nutt
Journal of Psychopharmacology (Oxford, England)|December 24, 2025
Farewell to Jim Watson (and Francis Crick). A reflection on their contributions to psychiatry and brain scienceDavid J Nutt
BMJ (Clinical Research Ed.)|February 3, 2011
NHS drug budget. Flawed assumption in analysisDavid J Nutt
Journal of Psychopharmacology (Oxford, England)|February 12, 2004
Death and dependence: current controversies over the selective serotonin reuptake inhibitorsDavid J Nutt
CNS Spectrums|December 25, 2004
Overview of diagnosis and drug treatments of anxiety disordersDavid J Nutt
Journal of Psychopharmacology (Oxford, England)|December 16, 2005
Informed consent--a new approach to drug regulation?David J Nutt
The Journal of Clinical Psychiatry|June 24, 2008
Relationship of neurotransmitters to the symptoms of major depressive disorderDavid J Nutt
Journal of Psychopharmacology (Oxford, England)|November 12, 2016
Thirty years of Journal of PsychopharmacologyDavid J Nutt
Pageof 39

Showing results (11-20 of 388) with videos related to

Sort By:
Pageof 39
Human Psychopharmacology|October 31, 2002
Tolerability and safety aspects of mirtazapineDavid J Nutt
Journal of Psychopharmacology (Oxford, England)|May 13, 2005
Making sense of GABA(A) receptor subtypes: is a new nomenclature needed?David J Nutt
Journal of Psychopharmacology (Oxford, England)|September 30, 2003
The unhappy saga of 'happy pills'David J Nutt
Journal of Psychopharmacology (Oxford, England)|December 24, 2025
Farewell to Jim Watson (and Francis Crick). A reflection on their contributions to psychiatry and brain scienceDavid J Nutt
BMJ (Clinical Research Ed.)|February 3, 2011
NHS drug budget. Flawed assumption in analysisDavid J Nutt
Journal of Psychopharmacology (Oxford, England)|February 12, 2004
Death and dependence: current controversies over the selective serotonin reuptake inhibitorsDavid J Nutt
CNS Spectrums|December 25, 2004
Overview of diagnosis and drug treatments of anxiety disordersDavid J Nutt
Journal of Psychopharmacology (Oxford, England)|December 16, 2005
Informed consent--a new approach to drug regulation?David J Nutt
The Journal of Clinical Psychiatry|June 24, 2008
Relationship of neurotransmitters to the symptoms of major depressive disorderDavid J Nutt
Journal of Psychopharmacology (Oxford, England)|November 12, 2016
Thirty years of Journal of PsychopharmacologyDavid J Nutt
Pageof 39